Edmond DE Rothschild Holding S.A. Has $59.60 Million Stock Position in Metlife Inc (NYSE:MET)

Edmond DE Rothschild Holding S.A. decreased its holdings in shares of Metlife Inc (NYSE:MET) by 11.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,400,119 shares of the financial services provider’s stock after selling 175,424 shares during the period. Metlife makes up 2.1% of Edmond DE Rothschild Holding S.A.’s portfolio, making the stock its 9th biggest holding. Edmond DE Rothschild Holding S.A. owned 0.15% of Metlife worth $59,603,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Citizens Financial Group Inc RI grew its stake in shares of Metlife by 12.7% in the first quarter. Citizens Financial Group Inc RI now owns 1,945 shares of the financial services provider’s stock worth $83,000 after acquiring an additional 219 shares during the last quarter. YorkBridge Wealth Partners LLC lifted its position in Metlife by 2.7% in the first quarter. YorkBridge Wealth Partners LLC now owns 8,566 shares of the financial services provider’s stock worth $365,000 after purchasing an additional 224 shares during the period. Parkside Financial Bank & Trust lifted its position in Metlife by 14.0% in the first quarter. Parkside Financial Bank & Trust now owns 1,849 shares of the financial services provider’s stock worth $79,000 after purchasing an additional 227 shares during the period. Stratos Wealth Partners LTD. lifted its holdings in shares of Metlife by 0.9% during the first quarter. Stratos Wealth Partners LTD. now owns 27,109 shares of the financial services provider’s stock valued at $1,154,000 after acquiring an additional 229 shares during the period. Finally, CWM LLC lifted its holdings in shares of Metlife by 27.6% during the first quarter. CWM LLC now owns 1,254 shares of the financial services provider’s stock valued at $53,000 after acquiring an additional 271 shares during the period. Institutional investors own 75.66% of the company’s stock.

NYSE MET traded up $0.52 during trading on Friday, hitting $49.67. The stock had a trading volume of 4,119,966 shares, compared to its average volume of 5,248,131. Metlife Inc has a 12 month low of $37.76 and a 12 month high of $50.40. The firm has a market cap of $47.27 billion, a P/E ratio of 9.22, a PEG ratio of 1.03 and a beta of 1.11. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.14 and a quick ratio of 0.14. The company has a 50-day moving average price of $48.07.

Metlife (NYSE:MET) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.30 by $0.18. The company had revenue of $15.45 billion for the quarter, compared to analysts’ expectations of $15.95 billion. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The business’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.36 EPS. Sell-side analysts expect that Metlife Inc will post 5.61 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 13th. Shareholders of record on Tuesday, May 7th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 3.54%. This is a positive change from Metlife’s previous quarterly dividend of $0.42. The ex-dividend date was Monday, May 6th. Metlife’s dividend payout ratio is currently 32.65%.

A number of research firms recently issued reports on MET. Sandler O’Neill cut Metlife from a “buy” rating to a “hold” rating and set a $50.00 price target for the company. in a report on Tuesday, March 19th. ValuEngine lowered Metlife from a “hold” rating to a “sell” rating in a research report on Wednesday, March 20th. Deutsche Bank boosted their target price on Metlife from $46.00 to $47.00 and gave the stock a “hold” rating in a research report on Friday, April 12th. UBS Group boosted their target price on Metlife from $45.00 to $48.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 9th. Finally, Wells Fargo & Co reiterated a “buy” rating and set a $55.00 price objective on shares of Metlife in a report on Tuesday, May 21st. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company’s stock. Metlife has a consensus rating of “Hold” and an average target price of $50.59.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: Why are percentage decliners important?

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.